Misplaced Pages

EpiVax

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
American biotechnology company

EpiVax is an American biotechnology company based in Rhode Island. The company was founded in 1998 by Anne Searls De Groot, who serves as its CEO and CSO. EpiVax holds the exclusive license to the EpiMatrix vaccine design technology. In 2020 it developed a COVID-19 vaccine, EPV-CoV19, in partnership with the University of Georgia and Immunomic Therapeutics.

References

  1. Graves, Helen (October 1, 2009). "Annie De Groot proves the power of one person". Boston Herald. Retrieved July 30, 2021.
  2. ^ "URI professor, vaccine pioneer honored by University of Chicago". URI News. University of Rhode Island. June 11, 2018. Retrieved July 30, 2021.
  3. MacMillan, John (June 15, 2020). "Dr. Annie De Groot '78: Designing a Vaccine". Grécourt Gate. Smith College. Retrieved July 30, 2021.
  4. Berkowitz, Bram (September 1, 2020). "Ocean State Update: The biggest Rhode Island tech and startup news From August". Rhode Island Innovation. Retrieved July 30, 2021.
  5. "7 Major Coronavirus Developments — RI's EpiVax to Raise $1.75M for Clinical Trial for Vaccine". GoLocalProv. April 8, 2020. Retrieved July 30, 2021.
  6. Tognini, Giacomo (April 1, 2020). "Coronavirus Business Tracker: How The Private Sector Is Fighting The Covid-19 Pandemic". Forbes. Retrieved July 30, 2021.

External links

Categories: